UiPath Inc. (NYSE:PATH) Shares Bought by Edgestream Partners L.P.

Edgestream Partners L.P. raised its holdings in UiPath Inc. (NYSE:PATH) by 73.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 403,098 shares of the healthcare company’s stock after purchasing an additional 170,426 shares during the quarter. Edgestream Partners L.P.’s holdings in UiPath were worth $5,111,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in shares of UiPath by 5.6% in the first quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock valued at $911,741,000 after acquiring an additional 2,133,078 shares in the last quarter. State Board of Administration of Florida Retirement System boosted its holdings in shares of UiPath by 0.5% in the first quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock valued at $6,696,000 after acquiring an additional 1,571 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp boosted its holdings in shares of UiPath by 4.2% in the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company’s stock valued at $5,240,000 after acquiring an additional 9,393 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in shares of UiPath by 245.1% in the first quarter. Acadian Asset Management LLC now owns 45,700 shares of the healthcare company’s stock valued at $1,032,000 after acquiring an additional 32,456 shares in the last quarter. Finally, Neuberger Berman Group LLC boosted its holdings in shares of UiPath by 38.4% in the fourth quarter. Neuberger Berman Group LLC now owns 20,133 shares of the healthcare company’s stock valued at $500,000 after acquiring an additional 5,586 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Ashim Gupta sold 47,671 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares of the company’s stock, valued at $10,258,498.19. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 22.37% of the company’s stock.

UiPath Price Performance

Shares of NYSE PATH opened at $12.27 on Wednesday. The firm’s 50-day moving average is $12.12 and its two-hundred day moving average is $16.06. The company has a market capitalization of $7.03 billion, a PE ratio of -76.69 and a beta of 0.87. UiPath Inc. has a 12-month low of $10.37 and a 12-month high of $27.87.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The business had revenue of $316.00 million during the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The company’s revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.09) earnings per share. On average, analysts forecast that UiPath Inc. will post -0.23 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on PATH. KeyCorp reaffirmed a “sector weight” rating on shares of UiPath in a report on Thursday, May 30th. DA Davidson boosted their price objective on shares of UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Wells Fargo & Company boosted their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a report on Friday, September 6th. Scotiabank decreased their price objective on shares of UiPath from $30.00 to $25.00 and set a “sector perform” rating on the stock in a report on Wednesday, May 29th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $16.00 price objective on shares of UiPath in a report on Friday, September 6th. Sixteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $17.71.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.